Bringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn MoreConnecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MOREEmpowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn moreWorking across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MOREDelivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn moreClinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn MoreHarness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MOREPharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MOREPrimary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORETrusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MOREOptimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MOREA single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MOREConnected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"Unlocking Pharmaceutical Potential: The Growing Role of Thai Clinics
Read moreImproving human health needs innovative thinkers. Unleash your potential with us.
Search JobsDiscover how industry experts recognize IQVIA's impact across the Asia Pacific region.
LEARN MOREOn June 24, 2025, a webinar will be hosted for U.S.-based customers from EBPs, large pharma, and mid-pharma segments, focusing on the evolving vaccine trials landscape in Southeast Asia. The session will begin with an introduction by Raina Singh, who will set the stage for the discussions ahead. Benjamin Laverty is scheduled to present a concise overview of the current vaccine trial environment in the region, touching on regulatory developments, trial site readiness, and emerging opportunities for collaboration.
The highlight of the session will be a panel discussion moderated by Raina Singh, featuring key opinion leaders from the Philippines, Pakistan, Thailand, Malaysia, and Vietnam. These experts will share their country-specific perspectives, challenges, and experiences in conducting vaccine trials, offering a comparative view of the clinical research landscape across Southeast Asia.
The webinar will conclude with a Q&A session, where Raina Singh will address audience questions and wrap up the discussion. This session aims to foster cross-regional knowledge exchange and highlight Southeast Asia’s growing potential as a strategic hub for vaccine development.
Speakers:
Jarir At Thobari
Professor, Department of Pharmacology and Therapy at Universitas Gadjah Mada (UGM)
Prof. Dr. Punnee Pitisuttithum
Project Chair of the Vaccine Trial Centre (VTC)
Dr. Syed Asad Ali
Chair, Department of Community Health Sciences Noordin Noormahomed Sheriff Endowed
Maria Rosario Z. Capeding, M.D.
Pediatric Infectious Disease Specialist and Clinical Researcher
Assoc. Prof. Vu Dinh Thiem, MD., PhD.
Director, Center for Clinical Trials at the National Institute of Hygiene and Epidemiology (NIHE)
Kevin O'Brien, MD
VP and Global Head, Infectious Disease & Vaccines and Allergy Respiratory Centers of Excellence
Benjamin Laverty
Head of R&DS Operations - Australia, New Zealand and Southeast Asia, IQVIA
Raina Singh Paplikar
Head- Marketing & Corporate Communications R&DS APAC, IQVIA